Assessing response to etidronate in osteoporosis.

被引：0
|
作者：
Crilly, R [1 ]
Hodsman, A [1 ]
Platt, N [1 ]
Cook, C [1 ]
机构：
[1] UNIV WESTERN ONTARIO,OSTEOPOROSIS CLIN,LONDON,ON N6C 5J1,CANADA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1996年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：M643 / M643
页数：1
相关论文
共 50 条
  • [1] Predicting response to etidronate in osteoporosis.
    Crilly, R
    Hodsman, A
    Platt, N
    Cook, C
    Adachi, J
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 664 - 664
  • [2] Treatment with etidronate or alendronate in postmenopausal osteoporosis.
    Lissens, MA
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S277 - S277
  • [3] Intermittent cyclical therapy with etidronate in the prevention of corticosteroid-induced osteoporosis.
    Bensen, WG
    Adachi, JD
    Anastassiades, TP
    Brown, JP
    Chines, AA
    Olszynski, WP
    Hanly, JG
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1773 - 1773
  • [4] The intermittent cyclic etidronate treatment is effective for the age-related osteoporosis.
    Takada, J
    Matsuyama, T
    Saino, H
    Nishi, M
    Ishii, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S275 - S275
  • [5] Comparison of BMD measurements at 6 and 12 months in assessing response to etidronate in osteoporosis
    Crilly, R
    Sebaldt, RJ
    Adachi, JD
    Brown, JP
    Hanley, DA
    Olszynski, WP
    Petrie, A
    SteMarie, LG
    Hodsman, AB
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S486 - S486
  • [6] Comparison of the efficiency and safety of cyclic etidronate versus sodium fluoride in postmenopausal osteoporosis.
    Guanabens, N
    Farrerons, J
    PerezEdo, L
    Monegal, A
    Renau, A
    Roca, M
    Pavesi, M
    Carbonell, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M653 - M653
  • [7] Effect of cyclical etidronate and testosterone therapy on bone mineral density in men with osteoporosis.
    Aretxabala, I
    Pande, I
    Woolf, AD
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S288 - S288
  • [8] Intermittent cyclical etidronate therapy in the prevention and treatment of corticosteroid-induced osteoporosis.
    Adachi, J
    Roux, C
    Moniz, C
    Geusens, P
    Dequeker, J
    Webber, D
    Pack, S
    Ethgen, D
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 628 - 628
  • [9] Age-related efficacy of alendronate, risedronate, and etidronate in postmenopausal women with osteoporosis.
    Ishida, Y.
    Taguchi, T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S15 - S15
  • [10] Osteoporosis.
    Cimaz R.
    Biggioggero M.
    Current Rheumatology Reports, 2001, 3 (5) : 365 - 370
12345